Could cannabis be the alternative of choice to traditional benzodiazepine painkillers? For the first time, a study has provided some answers to this question. The results are most encouraging, with almost one in two patients replacing these addictive tranquilizers with cannabis.
Conducted in Canada at a Canabo Group clinic, an evaluation of the use of cannabis in the treatment of benzodiazepine addiction revealed highly promising results. By the end of the trial, 45.2% of participants had weaned themselves off benzodiazepines, while being offered the choice of taking weed or a pill every day.
30% of patients stop taking benzodiazepines after one month of cannabis treatment
The study involved 146 volunteers who had been benzodiazepine users for several years. The average age of the research participants was 47. The gender breakdown showed a 61% female to 39% male ratio. Representatives of the fairer sex traditionally consume more benzodiazepines than those of the fairer sex. Finally, of these 146 patients, 54% had already tried cannabis recreationally.
In detail, 30.1% of patients were able to do without benzodiazepines after one month of treatment with therapeutic cannabis. This rose to 44.5% after two months and 45.2% after 3 months, i.e. at the end of the evaluation.
Six months later, none of the weaned patients had relapsed.
Six months later, none of the weaned patients had relapsed.
